Wogonin suppresses colorectal carcinogenesis by dually targeting the gut microbiota and host PLCγ1-dependent signaling
Journal of Pharmaceutical Analysis · 2026-11 · 101829
DOI: 10.1016/j.jpha.2026.101829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-11. Verfasst von Jiashu Pan und 8 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The global burden of colorectal cancer (CRC) underscores the urgent need for innovative intervention strategies targeting the complex host-microenvironment interactions. The natural flavonoid wogonin (Wog) emerges as a promising candidate; however, its mechanism of action in CRC remains unclear. Here, using murine models of chronic colitis and colitis-associated cancer, we demonstrate that Wog ameliorates intestinal inflammation and tumorigenesis. Multi-omics analyses revealed that Wog concurrently restructures the gut microbiota and significantly reduces fecal levels of diacylglycerol (DAG), an oncogenic lipid second messenger. Importantly, Wog remained effective in microbiota-depleted mice and continued to reduce intestinal DAG levels, indicating a direct host-targeted mechanism. Further investigation identified phospholipase Cγ1 (PLCγ1) as a crucial mediator, with Wog directly binding to Arg116 of PLCγ1, thereby inhibiting its phosphorylation and subsequent host-derived DAG production. This interaction ultimately suppresses the protein kinase Cα (PKCα)/mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling cascade. The significance of this mechanism was confirmed by the loss of Wog's efficacy following PLCγ1 knockdown or Arg116 mutation. Our findings establish Wog as a dual-action agent that integrates microbiota remodeling with direct PLCγ1 inhibition, presenting a novel strategy for CRC interception.
Zitieren
APA
Pan, J., Lu, L., Wang, Q., Xu, X., Nie, S., Lin, Z., Liu, S., Ji, G., & Xu, H. (2026). Wogonin suppresses colorectal carcinogenesis by dually targeting the gut microbiota and host PLCγ1-dependent signaling. Journal of Pharmaceutical Analysis, 101829. https://doi.org/10.1016/j.jpha.2026.101829
Vancouver
Pan J, Lu L, Wang Q, Xu X, Nie S, Lin Z, et al. Wogonin suppresses colorectal carcinogenesis by dually targeting the gut microbiota and host PLCγ1-dependent signaling. Journal of Pharmaceutical Analysis. 2026:101829. doi:10.1016/j.jpha.2026.101829
BibTeX
@article{Pan2026,
author = {Pan, Jiashu and Lu, Lu and Wang, Qun and Xu, Xiangyuan and Nie, Shuchang and Lin, Zemin and Liu, Sanhong and Ji, Guang and Xu, Hanchen},
title = {Wogonin suppresses colorectal carcinogenesis by dually targeting the gut microbiota and host PLCγ1-dependent signaling},
journal = {Journal of Pharmaceutical Analysis},
year = {2026},
pages = {101829},
doi = {10.1016/j.jpha.2026.101829}
}
EUVIMED